Exact Sciences and Guardant Health have both enjoyed triple-digit revenue growth over the past five years. Exact Sciences' shares are up more than 31% so far this year, while Guardant is up a little m
Guardant Health (GH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Why Guardant Health Stock Jumped 15% This Week

04:22pm, Thursday, 28'th Sep 2023
Analysts at both Bernstein and Piper Sandler had good things to say about Guardant Health this week. Shares of the precision oncology company had plunged more than 35% in September despite a lack of c

Why Guardant Health Stock Popped Again Today

11:25am, Thursday, 28'th Sep 2023
Guardant Health stock has lost half its value over the past year. That's the bad news.
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming Morgan Stanley 21st Annual Gl
The average of price targets set by Wall Street analysts indicates a potential upside of 42.1% in Guardant Health (GH). While the effectiveness of this highly sought-after metric is questionable, the

2 Cathie Wood Stocks to Buy and Hold for 10 Years

09:53am, Thursday, 10'th Aug 2023
Guardant Health's fight against cancer is also proving to be profitable for the company. Pinterest is looking to benefit from e-commerce in addition to its advertising business.
Guardant Health, Inc. (NASDAQ:GH ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Carrie Mendivil - IR Helmy Eltoukhy - Co-Founder, Co-CEO & Chairman AmirAli Talasaz -
Guardant Health (GH) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $1.25. This compares to loss of $2.25 per share a year ago.
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will report financial results for the second quarter of 2023 a
Guardant Health's share price has been volatile over the past year, but with strong clinical volume growth, the company presents an interesting investment opportunity. The company has diversified its
#Morningstar #StockMarket #Investing Plus our take on Nvidia stock and our market outlook for June. Read more from David Sekera here: https://www.morningstar.com/stocks/2-undervalued-medtech-stocks-op
Guardant Health Inc. GH, +2.46% shares fell in the extended session Monday after the cancer testing company announced a secondary offering of its stock. Guardant shares rose as much as 8% after hours,

Why Shares of Guardant Health Jumped This Week

05:50pm, Friday, 19'th May 2023
Guardant said its Guardant360 liquid biopsy is receiving coverage from all four major U.S. health insurers. The company grew revenue by 34% in the first quarter, year over year, but had a net loss.
Guardant Health, Inc. (NASDAQ:GH ) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Alex Kleban - Vice President-Investor Relations Helmy Eltoukhy - Chairman & Co-Chief Exe
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE